Literature DB >> 33420588

Serotonergic Facilitation of Forelimb Functional Recovery in Rats with Cervical Spinal Cord Injury.

Benita Jin1, Monzurul Alam1, Alexa Tierno1, Hui Zhong1, Roland R Roy1,2, Yury Gerasimenko1,3,4, Daniel C Lu5, V Reggie Edgerton6,7,8,9,10,11.   

Abstract

Serotonergic agents can improve the recovery of motor ability after a spinal cord injury. Herein, we compare the effects of buspirone, a 5-HT1A receptor partial agonist, to fluoxetine, a selective serotonin reuptake inhibitor, on forelimb motor function recovery after a C4 bilateral dorsal funiculi crush in adult female rats. After injury, single pellet reaching performance and forelimb muscle activity decreased in all rats. From 1 to 6 weeks after injury, rats were tested on these tasks with and without buspirone (1-2 mg/kg) or fluoxetine (1-5 mg/kg). Reaching and grasping success rates of buspirone-treated rats improved rapidly within 2 weeks after injury and plateaued over the next 4 weeks of testing. Electromyography (EMG) from selected muscles in the dominant forelimb showed that buspirone-treated animals used new reaching strategies to achieve success after the injury. However, forelimb performance dramatically decreased within 2 weeks of buspirone withdrawal. In contrast, fluoxetine treatment resulted in a more progressive rate of improvement in forelimb performance over 8 weeks after injury. Neither buspirone nor fluoxetine significantly improved quadrupedal locomotion on the horizontal ladder test. The improved accuracy of reaching and grasping, patterns of muscle activity, and increased excitability of spinal motor-evoked potentials after buspirone administration reflect extensive reorganization of connectivity within and between supraspinal and spinal sensory-motor netxcopy works. Thus, both serotonergic drugs, buspirone and fluoxetine, neuromodulated these networks to physiological states that enabled markedly improved forelimb function after cervical spinal cord injury.
© 2020. The American Society for Experimental NeuroTherapeutics, Inc.

Entities:  

Keywords:  Buspirone; Fluoxetine; Forelimb; Serotonin; Spinal cord injury

Mesh:

Substances:

Year:  2021        PMID: 33420588      PMCID: PMC8423890          DOI: 10.1007/s13311-020-00974-8

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   7.620


  1 in total

1.  Improvement of grasping after motor imagery in C6-C7 tetraplegia: A kinematic and MEG pilot study.

Authors:  Sébastien Mateo; Franck Di Rienzo; Karen T Reilly; Patrice Revol; Claude Delpuech; Sébastien Daligault; Aymeric Guillot; Sophie Jacquin-Courtois; Jacques Luauté; Yves Rossetti; Christian Collet; Gilles Rode
Journal:  Restor Neurol Neurosci       Date:  2015       Impact factor: 2.406

  1 in total
  2 in total

Review 1.  Serotonin 1A Receptor Pharmacotherapy and Neuroplasticity in Spinal Cord Injury.

Authors:  Afaf Bajjig; Florence Cayetanot; J Andrew Taylor; Laurence Bodineau; Isabelle Vivodtzev
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-11

2.  Buspirone Dose-Response on Facilitating Forelimb Functional Recovery in Cervical Spinal Cord Injured Rats.

Authors:  Rakib Uddin Ahmed; V Reggie Edgerton; Shuai Li; Yong-Ping Zheng; Monzurul Alam
Journal:  Dose Response       Date:  2021-02-27       Impact factor: 2.658

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.